Streetwise Reports Examines How a Canadian Medical

SAN FRANCISCO, CA --(Marketwired - July 28, 2017) - A company with Canadian medical cannabis provider Aphria's backing did a reverse takeover on the Canadian Securities Exchange and began trading on July 26.

Included in this article is: Liberty Health Sciences Inc. ( CSE : LHS ) ( CSE : LHS.CN ) ( CNSX : LHS )

Liberty Health Sciences Inc. , an operator in the medical cannabis market, began trading on the Canadian Securities Exchange on Wednesday, July 26, under the symbol LHS. The company is being formed through a reverse takeover with privately held DFMMJ Investment Ltd. and SecureCom Mobile Inc., whose shareholders approved the arrangement on July 20, and renamed Liberty Health Sciences.

In April, Aphria Inc. announced a $25 million investment in DFMMJ Investment Ltd. Aphria is licensing its Aphria medical brand as well as its greenhouse growing intellectual property system to Liberty.

According to the company , Aphria is one of Canada's lowest cost producers, and "produces, supplies and sells medical cannabis," and is "the first public licensed producer to report positive cash flow from operations and the first to report positive earnings in consecutive quarters."

Continue reading this article: Canadian Medical Cannabis Provider Expanding into US Market Through RTO

About Streetwise Reports - The Life Sciences Report

Investors rely on The Life Sciences Report to share investment ideas for the biotech, pharmaceutical, medical device, and diagnostics industries. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security.

DISCLOSURES:

The following company mentioned in this article is a billboard sponsor of Streetwise Reports: None. Streetwise Reports does not accept stock in exchange for its services. Click here for important disclosures about sponsor fees. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security. Comments and opinions expressed are those of the specific experts and not of Streetwise Reports or its officers.

Please see the end of the article for the complete disclosures: Canadian Medical Cannabis Provider Expanding into US Market Through RTO